Amedisys Inc. (NASDAQ: AMED) foresees strong growth moving forward, fed by demographic tailwinds and a greater shift of health care towards the home, which has been accelerated by COVID-19. A key strategy for the company as more chronically ill seniors age into Medicare is the build up of ancillary services such as personal care and […]
Amedisys Inc. (NASDAQ: AMED) and Option Care Health Inc. (NASDAQ: OPCH) have formed a partnership to issue a COVID-19 infusion therapy to patients in long-term care facilities throughout the Indianapolis and Valparaiso, Ind., markets. The effort is intended to assist residents in a setting hardest hit by the coronavirus pandemic. Amedisys felt well-poised to take […]
Reps. Brad Schneider (D-IL) and David McKinley (R-WV) have introduced the Medicare Sequester COVID Moratorium Act in the U.S. House of Representatives. The bill would extend the temporary suspension of Medicare sequestration payment reductions for hospices for the duration of the federally declared COVID-19 public health emergency. The U.S. Centers for Medicare & Medicaid Services (CMS) […]
While a growing demand for end-of-life care has been a major force pushing hospice to the forefront of the health care mergers and acquisitions marketplace, evolving payment models and COVID-19 headwinds have been hurdles to building up investor interest in 2020. Despite the unknowns ahead, hospice market is expected to burgeon. Among the various sectors […]
Post-acute care company Amedisys (NASDAQ: AMED) will be growing its referral network to include more non-institutional providers due to a shifting patient mix brought on by COVID-19. The pandemic has led to a drop in referrals from institutional health care providers, but created an uptick among other organizations that transition eligible patients to hospice. The […]
The U.S. Supreme Court is mulling whether it will hear arguments in a False Claims Act (FCA) case involving the hospice provider Care Alternatives. FCA actions pertaining to hospices most commonly focus on questions of a patient’s eligibility for those services. A 2019 report from the law firm of Bass, Barry, and Sims indicated that […]
Amedisys Inc. (NASDAQ: AMED) has continued to grow its hospice segment despite facing COVID-19 headwinds earlier this year. This expansion deepens an industry-wide trend toward service diversification and a lean towards value-based programming. The company is citing rising demand for palliative care as an impetus for moving into that space. “Palliative care is a nice […]
Consolidation is a growing trend in the hospice market, leading to a shrinking number of providers nationwide as smaller hospices get absorbed by larger organizations. Hospice topped other health care sectors in merger and acquisition activity this year, despite economic downturn during the COVID-19 pandemic. While M&A transactions slowed significantly early in 2020 as providers […]
Amedisys, Inc. (NASDAQ: AMED) anticipates more hospice merger and acquisitions in 2020 despite raging COVID-19 headwinds. Recovering from a drop in referrals and rising COVID-related costs during the first and second quarters, the company expects their hospice segment to grow consistently in coming years. The company has been very active in the M&A market. Acquisitions […]
Hospice and home health care provider Amedisys, Inc. (NASDAQ: AMED), has forged a partnership with BrightStar Care, which will begin offering personal care services through Amedisys Personal Care Network. Amedisys’ network helps to coordinate care between the company’s home health and hospice operations as well as partner organizations that provide personal care, such as BrightStar. […]